Skip to main content
Clinical Trials/CTRI/2019/01/017177
CTRI/2019/01/017177
Completed
未知

Serum Paraoxonase 1, Myeloperoxidase activity and their association with Atherogenic Index of Plasma in patients with Dyslipidemia

Tejal Deepak Durgekar0 sites143 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: I709- Other and unspecified atherosclerosis
Sponsor
Tejal Deepak Durgekar
Enrollment
143
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
April 4, 2019
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Tejal Deepak Durgekar

Eligibility Criteria

Inclusion Criteria

  • 1\. Healthy controls with normal lipid profile.
  • 2\.Patients having dyslipidemia with and without cardiovascular complications will be included.

Exclusion Criteria

  • 1\. Patients with renal failure, chronic Kidney Disease, triglycerides levels greater than 500 mg/dl, diabetes with glycated Hemoglobin greater than 9 will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials